Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine|September 13, 2018
Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative reviewMohamed Abbas, Daniela Pires, Alexandra Peters, et al.
Journal of Pain and Symptom Management|May 29, 2016
Phase I Cancer Trials and Palliative Care: Antagonism, Irrelevance, or Synergy?J Brian Cassel, Egidio Del Fabbro, Tobias Arkenau, et al.
Neurobiology of Aging|March 21, 2017
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issuesCorinna Porteri, Emiliano Albanese, Charles Scerri, et al.
Vaccine|September 28, 2020
Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next stepsRieke van der Graaf, Ruth Macklin, Annette Rid, et al.
BMC Medical Ethics|November 4, 2025
Association between critical care occupancy and code status decisions during resource scarcity: a retrospective cohort studyStijn Bex, Lorna Guinness, Christophe Gaudet-Blavignac, et al.
Bulletin of the World Health Organization|February 8, 2021
Immunity certification for COVID-19: ethical considerationsTeck Chuan Voo, Andreas A Reis, Beatriz Thomé, et al.
Scandinavian Journal of Public Health|October 19, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based studyAude Richard, Ania Wisniak, Javier Perez-Saez, et al.
JMIR Rehabilitation and Assistive Technologies|August 18, 2025
Challenges and Opportunities of the Human-Centered Design Approach: Case Study Development of an Assistive Device for the Navigation of Persons With Visual ImpairmentMario Andres Chavarria, Luisa María Ortiz-Escobar, Bladimir Bacca-Cortes, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Thrombosis and Haemostasis|July 14, 2026
Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS projectFrancis Couturaud, David Jiménez, Olivier Sanchez, et al.
Pageof 7